JP2020527540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527540A5 JP2020527540A5 JP2019569444A JP2019569444A JP2020527540A5 JP 2020527540 A5 JP2020527540 A5 JP 2020527540A5 JP 2019569444 A JP2019569444 A JP 2019569444A JP 2019569444 A JP2019569444 A JP 2019569444A JP 2020527540 A5 JP2020527540 A5 JP 2020527540A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- dendritic cells
- bid
- dengue virus
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520345P | 2017-06-15 | 2017-06-15 | |
| US62/520,345 | 2017-06-15 | ||
| PCT/US2018/037616 WO2018232166A1 (en) | 2017-06-15 | 2018-06-14 | Compositions and methods for cancer therapy with dengue virus and dendritic cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020527540A JP2020527540A (ja) | 2020-09-10 |
| JP2020527540A5 true JP2020527540A5 (https=) | 2021-07-26 |
Family
ID=64660234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569444A Pending JP2020527540A (ja) | 2017-06-15 | 2018-06-14 | デングウイルスならびに樹状細胞を用いた癌治療のための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20200121745A1 (https=) |
| EP (1) | EP3638303A4 (https=) |
| JP (1) | JP2020527540A (https=) |
| KR (1) | KR20200023375A (https=) |
| CN (1) | CN110996997A (https=) |
| AU (1) | AU2018285525A1 (https=) |
| EA (1) | EA201992863A1 (https=) |
| IL (1) | IL271442A (https=) |
| MX (1) | MX2019015194A (https=) |
| SG (1) | SG11201912163WA (https=) |
| WO (1) | WO2018232166A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9730989B2 (en) | 2015-07-02 | 2017-08-15 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for combination therapy with dengue virus and dendritic cells |
| CA2999881A1 (en) | 2015-09-26 | 2017-03-30 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for producing dendritic cells |
| JP2020500847A (ja) | 2016-11-16 | 2020-01-16 | プライムヴァックス イミュノ−オンコロジー，インク． | 癌の処置のための併用免疫療法 |
| EP3565567A4 (en) | 2017-01-04 | 2020-07-29 | Primevax Immuno-Oncology, Inc. | COMPOSITIONS AND METHODS OF THERAPY WITH DENGUE VIRUS |
| WO2021235506A1 (ja) * | 2020-05-21 | 2021-11-25 | 国立大学法人大阪大学 | 上皮癌治療薬 |
| CN116546999A (zh) * | 2020-09-27 | 2023-08-04 | 深圳华大生命科学研究院 | 药物组合物及其制备方法和应用 |
| CN116333969A (zh) * | 2023-02-01 | 2023-06-27 | 宁波荣安生物药业有限公司 | 一种狂犬病毒用Vero细胞培养方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2872199A (en) * | 1998-02-20 | 1999-09-06 | Rockefeller University, The | Apoptotic cell-mediated antigen presentation to dendritic cells |
| US6524587B1 (en) * | 1998-05-05 | 2003-02-25 | Bruce W. Lyday | Hyperthermia and immunotherapy for leukemias lymphomas, and solid tumors |
| EP1165127B1 (en) * | 1999-03-26 | 2008-12-31 | Walter Reed Army Institute of Research | Multivalent dengue virus vaccine |
| US9730989B2 (en) * | 2015-07-02 | 2017-08-15 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for combination therapy with dengue virus and dendritic cells |
| CA2999881A1 (en) * | 2015-09-26 | 2017-03-30 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for producing dendritic cells |
| EP3565567A4 (en) * | 2017-01-04 | 2020-07-29 | Primevax Immuno-Oncology, Inc. | COMPOSITIONS AND METHODS OF THERAPY WITH DENGUE VIRUS |
-
2018
- 2018-06-14 SG SG11201912163WA patent/SG11201912163WA/en unknown
- 2018-06-14 AU AU2018285525A patent/AU2018285525A1/en not_active Abandoned
- 2018-06-14 EP EP18817312.4A patent/EP3638303A4/en not_active Withdrawn
- 2018-06-14 MX MX2019015194A patent/MX2019015194A/es unknown
- 2018-06-14 CN CN201880052913.4A patent/CN110996997A/zh active Pending
- 2018-06-14 JP JP2019569444A patent/JP2020527540A/ja active Pending
- 2018-06-14 KR KR1020207001386A patent/KR20200023375A/ko not_active Ceased
- 2018-06-14 WO PCT/US2018/037616 patent/WO2018232166A1/en not_active Ceased
- 2018-06-14 EA EA201992863A patent/EA201992863A1/ru unknown
-
2019
- 2019-12-13 US US16/714,370 patent/US20200121745A1/en not_active Abandoned
- 2019-12-15 IL IL271442A patent/IL271442A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020527540A5 (https=) | ||
| JP2017048208A5 (https=) | ||
| JP2011251975A5 (https=) | ||
| JP2015157821A5 (https=) | ||
| CY1116874T1 (el) | Δοσολογικο σχημα για τη χορηγηση ενος cd19xcd3 αμφιειδικου αντισωματος | |
| RU2017132877A (ru) | Комбинация антагониста pd-1 и эрибулина для лечения рака | |
| SI2523688T1 (en) | Formulation of antibodies and therapeutic regimes | |
| JP2013505205A5 (https=) | ||
| CY1111259T1 (el) | Απο του στοματος εντερικη στερεα μορφη δοσολογιας ενος δισφωσφονικου που περιεχει παραγοντα χηλικης συμπλεξης | |
| RU2014114221A (ru) | Композиции и способы доставки фармакологических агентов | |
| JP2016512248A5 (https=) | ||
| EA200870480A1 (ru) | Новые композиции, стабилизирующие иммуногенные композиции и ингибирующие их осаждение | |
| MX2007005179A (es) | Formas de dosificacion. | |
| JP2014515036A5 (https=) | ||
| AR057180A1 (es) | Formulacion farmaceutica de absorcion oral que comprende insulina, entre otros, y su metodo de administracion | |
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| TW200418517A (en) | Liquid pharmaceutical formulations of palonosetron | |
| MX2009012598A (es) | Formas de dosis que comprenden vx-950 y su regimen de dosificacion. | |
| JP2019530706A5 (https=) | ||
| Lei et al. | A vaccine delivery system promotes strong immune responses against SARS‐CoV‐2 variants | |
| Harper et al. | Review of gardasil | |
| JP2013541587A5 (https=) | ||
| JP2006508977A5 (https=) | ||
| JP2016537364A5 (https=) | ||
| Weiss | Immunotherapy for HIV infection |